Skip to main content

stock

RCKTW · ROCKET PHARMACEUTICALS, INC.

What ROCKET PHARMACEUTICALS, INC. reports to the SEC, read from its filings.

Open in the app

Price

The live RCKTW price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on RCKTW.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
109,774,597 as of 2026-07-31 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-4.7%
ROA
-4.1%

Health

Current ratio
9.2x
Debt/equity
—

Deep value

NCAV
$235.28M
NCAV per share
$2.14
Price/NCAV
Locked
NNWC
$170.24M
NNWC per share
$1.55
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$0—Gross profit: unreported by this company.-$46.92M$123.21M
10-Q filed 2026-08-10
2026-03-31$0—Gross profit: unreported by this company.-$48.51M-$47.59M
10-Q filed 2026-08-10
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$0—Gross profit: unreported by this company.-$43.96M-$42.54M
DEF 14A filed 2026-04-06
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$0—Gross profit: unreported by this company.-$52.25M-$50.33M
10-Q filed 2025-11-06
2025-06-30$0—Gross profit: unreported by this company.-$71.15M-$68.92M
10-Q filed 2026-08-10
2025-03-31$0—Gross profit: unreported by this company.-$64.39M-$61.33M
10-Q filed 2026-08-10
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$0—Gross profit: unreported by this company.-$62.69M-$60.33M
DEF 14A filed 2026-04-06
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$0—Gross profit: unreported by this company.-$69.42M-$66.72M
10-Q filed 2025-11-06
Assets
$423.10M
Equity
$368.83M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$0-$231.75M-$223.12M-$190.45M
2024-12-31$0-$273.20M-$258.75M-$215.59M
2023-12-31$0-$259.66M-$245.59M-$211.35M
2022-12-31$0-$224.34M-$221.86M-$186.50M
2021-12-31$0-$167.25M-$169.07M-$128.78M
2020-12-31$0-$134.30M-$139.70M-$95.25M
2019-12-31$0-$76.15M-$77.27M-$87.93M
2018-12-31$0-$71.16M-$74.52M-$55.24M
2017-12-31$0-$19.77M-$19.58M-$16.72M
2016-12-31$0-$7.57M-$7.57M-$5.84M

Company filings

since Mon Mar 2 · 1 offering filing in 12 months · since Tue Mar 10

events

  • Regulation FD disclosure

    Regulation FD disclosure
    Sep 158-K
  • Executive or director change

    Executive or director change
    Aug 278-K
  • Results

    Results
    Aug 108-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Aug 38-K
  • Executive or director change

    Executive or director change
    Jun 308-K
  • Acquisition or sale completed, Regulation FD disclosure

    Acquisition or sale completedRegulation FD disclosure
    Jun 128-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

Funds

News

Stories that named RCKTW, and the market events around them.

Sign in to see this

Board

The RCKTW board could not be loaded.

Retry the RCKTW board

nakagai

Signals on RCKTW come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the RCKTW board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

ROCKET PHARMACEUTICALS, INC. (RCKTW): SEC filings, financials and insider trades · Nakagai